{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:26:16Z","timestamp":1793791576930,"version":"4.6.1"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijcrp.2026.200710","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:52:57Z","timestamp":1789689177000},"page":"200710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systematic review of clinical guidance for lipid management in adults with or at risk of atherosclerotic cardiovascular disease: A global perspective"],"prefix":"10.1016","volume":"31","author":[{"given":"Katherine G.","family":"Akers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Frederickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori D.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1513-1715","authenticated-orcid":false,"given":"Xuehua","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8, Supplement","key":"10.1016\/j.ijcrp.2026.200710_bib1","first-page":"S4","article-title":"Dyslipidemia and the current state of cardiovascular disease: epidemiology, risk factors, and effect of lipid lowering","volume":"40","author":"Brunham","year":"2024","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200710_bib2","series-title":"World Heart Federation Cholesterol Roadmap 2022","author":"Ray","year":"2022"},{"key":"10.1016\/j.ijcrp.2026.200710_bib3","series-title":"Hypercholesterolemia. StatPearls. Treasure Island (FL)","author":"Ibrahim","year":"2024"},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40256-023-00594-5","article-title":"Established and emerging lipid-lowering drugs for primary and secondary cardiovascular prevention","volume":"23","author":"Michaeli","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101342","article-title":"Lipid lowering therapy: an era beyond statins","volume":"47","author":"Abdul-Rahman","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200710_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mayocp.2017.01.001","article-title":"Clinical practice guidelines: a primer on development and dissemination","volume":"92","author":"Murad","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"2_suppl","key":"10.1016\/j.ijcrp.2026.200710_bib7","first-page":"S1","article-title":"Clinical consensus statement development manual","volume":"153","author":"Rosenfeld","year":"2015","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200710_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2019.9751","article-title":"Evidence vs consensus in clinical practice guidelines","volume":"322","author":"Djulbegovic","year":"2019","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ijcrp.2026.200710_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11237249","article-title":"Comparison of current international guidelines for the management of dyslipidemia","volume":"11","author":"Aygun","year":"2022","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267445","article-title":"Mind the gap: mapping variation between national and local clinical practice guidelines for acute paediatric asthma from the United Kingdom and the Netherlands","volume":"17","author":"Koldeweij","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200710_bib11","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.21037\/jtd.2019.07.71","article-title":"Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying appraisal of Guidelines for Research and evaluation II-clinical practice guideline appraisal for lipid management in coronary heart disease","volume":"11","author":"Zhou","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/fampra\/cmae029","article-title":"Methodological quality and clinical recommendations of guidelines on the management of dyslipidaemias for cardiovascular disease risk reduction: a systematic review and an appraisal through AGREE II and AGREE REX tools","volume":"41","author":"Deffert","year":"2024","journal-title":"Fam. Pract."},{"key":"10.1016\/j.ijcrp.2026.200710_bib13","first-page":"70","article-title":"General practitioners' experiences with multiple clinical guidelines: a qualitative study from Norway","volume":"23","author":"Austad","year":"2015","journal-title":"Qual. Prim. Care"},{"key":"10.1016\/j.ijcrp.2026.200710_bib14","article-title":"Fixing clinical practice guidelines","author":"Benavidez","year":"2019","journal-title":"Health Affairs Forefront"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062158","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"issue":"10467","key":"10.1016\/j.ijcrp.2026.200710_bib16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200710_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"10431","key":"10.1016\/j.ijcrp.2026.200710_bib18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib19","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2666-7568(22)00074-5","article-title":"Improving clinical practice guidelines for older people: considerations and recommendations for more inclusive and ageing-relevant guidelines","volume":"3","author":"Hwang","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.ijcrp.2026.200710_bib20","article-title":"Barriers and solutions in women's health research and clinical care: a call to action","volume":"44","author":"Regensteiner","year":"2025","journal-title":"Lancet Reg. Health, Am."},{"key":"10.1016\/j.ijcrp.2026.200710_bib21","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijcrp.2026.200710_bib22","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"1","author":"Higgins","year":"2008"},{"key":"10.1016\/j.ijcrp.2026.200710_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jclinepi.2019.09.022","article-title":"Validation of five search filters for retrieval of clinical practice guidelines produced low precision","volume":"117","author":"Lunny","year":"2020","journal-title":"J. Clin. Epidemiol."},{"issue":"18","key":"10.1016\/j.ijcrp.2026.200710_bib27","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"Agree II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"issue":"13","key":"10.1016\/j.ijcrp.2026.200710_bib28","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.3390\/jcm12134312","article-title":"A Jordanian multidisciplinary consensus statement on the management of dyslipidemia","volume":"12","author":"Al Mousa","year":"2023","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/heartviews.heartviews_102_22","article-title":"2022 saudi guidelines for the management of dyslipidemia","volume":"24","author":"AlRahimi","year":"2023","journal-title":"Heart Views"},{"key":"10.1016\/j.ijcrp.2026.200710_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2021.11.022","article-title":"Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update","volume":"343","author":"Alsayed","year":"2022","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/jrms.jrms_318_23","article-title":"First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults","volume":"29","author":"Kholenjani","year":"2024","journal-title":"J. Res. Med. Sci."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200710_bib32","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.5114\/aoms\/141941","article-title":"PoLA\/CFPiP\/PCS\/PSLD\/PSD\/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021","volume":"17","author":"Banach","year":"2021","journal-title":"Arch. Med. Sci.: AMS"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib33","first-page":"354","article-title":"Dyslipidemia: recommendations for diagnosis and treatment at the first level of medical contact","volume":"160","author":"de Lourdes Basurto","year":"2024","journal-title":"Gac. Med. Mex."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ando.2016.11.001","article-title":"Consensus statement on the management of dyslipidaemias in adults","volume":"78","author":"B\u00e9liard","year":"2017","journal-title":"Ann. Endocrinol."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib35","first-page":"479","article-title":"2024 guidelines of the Taiwan society of cardiology on the primary prevention of atherosclerotic cardiovascular disease---Part I","volume":"40","author":"Chao","year":"2024","journal-title":"Acta Cardiol. Sin."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.acvd.2024.02.004","article-title":"Management of lipid variables in primary cardiovascular prevention: a position paper from the heart, vessels and metabolism group of the French society of cardiology","volume":"117","author":"Dievart","year":"2024","journal-title":"Archives of cardiovascular diseases"},{"issue":"24","key":"10.1016\/j.ijcrp.2026.200710_bib37","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.atherosclerosis.2013.11.031","article-title":"An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia: executive summary","volume":"232","author":"on Dyslipidemia","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/CD9.0000000000000025","article-title":"Chinese guideline on the primary prevention of cardiovascular diseases","volume":"1","author":"Hu","year":"2021","journal-title":"Cardiology Discovery"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1\u2014full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J. Clin. Lipidol."},{"issue":"43","key":"10.1016\/j.ijcrp.2026.200710_bib41","doi-asserted-by":"crossref","first-page":"E1460","DOI":"10.1503\/cmaj.220138","article-title":"Canadian cardiovascular harmonized national guideline endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update","volume":"194","author":"Jain","year":"2022","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.ijcrp.2026.200710_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American association of clinical endocrinologists and American college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr. Pract."},{"issue":"11b","key":"10.1016\/j.ijcrp.2026.200710_bib43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7196\/SAMJ.2018.v108i11.13383","article-title":"South African dyslipidaemia guideline consensus statement: 2018 update A joint statement from the South African heart association (SA heart) and the lipid and atherosclerosis society of Southern Africa (LASSA)","volume":"108","author":"Klug","year":"2018","journal-title":"South African medical journal"},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200710_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.46747\/cfp.6910675","article-title":"PEER simplified lipid guideline 2023 update: prevention and management of cardiovascular disease in primary care","volume":"69","author":"Kolber","year":"2023","journal-title":"Can. Fam. Physician"},{"issue":"14","key":"10.1016\/j.ijcrp.2026.200710_bib45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-Cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American college of cardiology solution set oversight committee","volume":"80","author":"Committee","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200710_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2478\/abm-2024-0033","article-title":"2024 the royal college of physicians of Thailand (RCPT) clinical practice guidelines on management of dyslipidemia for atherosclerotic cardiovascular disease prevention","volume":"18","author":"Lolekha","year":"2024","journal-title":"Asian Biomed.: Research, Reviews and News"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of cardiology (ESC) and european atherosclerosis society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.eprac.2024.09.016","article-title":"American association of clinical endocrinology clinical practice guideline on pharmacologic management of adults with dyslipidemia","volume":"31","author":"Patel","year":"2025","journal-title":"Endocr. Pract."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200710_bib50","first-page":"1129","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib51","first-page":"99","volume":"92","author":"Ponte-Negretti","year":"2022","journal-title":"Arch. Cardiol. Mex."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200710_bib52","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.jacl.2024.01.006","article-title":"Lipid association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: consensus statement IV","volume":"18","author":"Puri","year":"2024","journal-title":"J. Clin. Lipidol."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib53","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ihj.2018.03.011","article-title":"Adaptation of 2016 european society of cardiology\/european atherosclerosis society guideline for lipid management to Indian patients\u2013A consensus document","volume":"70","author":"Ray","year":"2018","journal-title":"Indian Heart J."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.12997\/jla.2019.8.2.78","article-title":"2018 guidelines for the management of dyslipidemia in Korea","volume":"8","author":"Rhee","year":"2019","journal-title":"Journal of lipid and atherosclerosis"},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200710_bib55","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2019-01338","article-title":"Primary prevention of ASCVD and T2DM in patients at metabolic risk: an endocrine society clinical practice guideline","volume":"104","author":"Rosenzweig","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200710_bib57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.7326\/M20-4648","article-title":"Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2020 updated US department of veterans affairs and US department of defense clinical practice guideline","volume":"173","author":"O'Malley","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"34","key":"10.1016\/j.ijcrp.2026.200710_bib58","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200710_bib59","series-title":"Management of Dyslipidemia 2017: 5Th Edition of Clinical Practice Guidelines. Ministry of Health Malaysia, Academy of Medicine Malaysia","year":"2017"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nrl.2020.07.027","article-title":"Dyslipidemias and stroke prevention: recommendations of the study group of cerebrovascular diseases of the Spanish society of neurology","volume":"37","author":"Palacio-Portilla","year":"2022","journal-title":"Neurologia"},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200710_bib61","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200710_bib62","article-title":"Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population","volume":"2017","author":"Cheung","year":"2016","journal-title":"Hong Kong Med. J."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15605\/jafes.036.01.01","article-title":"Executive Summary of the 2020 clinical practice guidelines for the management of dyslipidemia in the Philippines","volume":"36","author":"Gonzalez-Santos","year":"2021","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200710_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5551\/jat.GL2022","article-title":"Japan atherosclerosis society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022","volume":"31","author":"Okamura","year":"2024","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.ijcrp.2026.200710_bib65","article-title":"2023 Chinese guideline for lipid management","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijcrp.2026.200710_bib66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.athplu.2024.01.004","article-title":"Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias-2023","volume":"55","author":"Katsiki","year":"2024","journal-title":"Atherosclerosis plus"},{"key":"10.1016\/j.ijcrp.2026.200710_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069066","article-title":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations","volume":"377","author":"Hao","year":"2022","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.rce.2013.12.014","article-title":"Clinical decisions in patients with diabetes and other cardiovascular risk factors. A statement of the Spanish Society of internal medicine","volume":"214","author":"Gomez-Huelgas","year":"2014","journal-title":"Rev. Cl\u00ednica Espa\u00f1ola"},{"issue":"Suppl 2","key":"10.1016\/j.ijcrp.2026.200710_bib69","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","author":"Board","year":"2014","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.hlc.2025.02.102","article-title":"National heart foundation of Australia & cardiac society of Australia and New Zealand: comprehensive Australian clinical guideline for diagnosing and managing acute coronary syndromes 2025","volume":"34","author":"Brieger","year":"2025","journal-title":"Heart Lung Circ."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200710_bib71","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5694\/mja2.51482","article-title":"Management of type 2 diabetes in young adults aged 18\u201330 years: ADS\/ADEA\/APEG consensus statement","volume":"216","author":"Wong","year":"2022","journal-title":"Med. J. Aust."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib72","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacl.2017.05.001","article-title":"Update on the use of PCSK9 inhibitors in adults: recommendations from an expert panel of the national lipid association","volume":"11","author":"Orringer","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200710_bib73","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4158\/CS-2020-0490","article-title":"Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm\u20132020 executive summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200710_bib74","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/cjn.2021.127","article-title":"Canadian stroke best practice recommendations: secondary prevention of stroke update 2020","volume":"49","author":"Gladstone","year":"2022","journal-title":"Can. J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200710_bib75","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pcad.2016.08.004","article-title":"Cardiac rehabilitation delivery model for low-resource settings: an international council of cardiovascular prevention and rehabilitation consensus statement","volume":"59","author":"Grace","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"2 Suppl 1","key":"10.1016\/j.ijcrp.2026.200710_bib76","first-page":"1","article-title":"South American guidelines for cardiovascular disease prevention and rehabilitation","volume":"103","author":"Herdy","year":"2014","journal-title":"Arq. Bras. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcrp.2026.200710_bib77","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"85","author":"Rao","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib78","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s12325-020-01302-4","article-title":"A narrative review and expert panel recommendations on dyslipidaemia management after acute coronary syndrome in countries outside Western Europe and North America","volume":"37","author":"Reda","year":"2020","journal-title":"Adv. Ther."},{"issue":"36","key":"10.1016\/j.ijcrp.2026.200710_bib80","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200710_bib81","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873221100032","article-title":"European stroke organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack","volume":"7","author":"Dawson","year":"2022","journal-title":"European stroke journal"},{"key":"10.1016\/j.ijcrp.2026.200710_bib82","doi-asserted-by":"crossref","DOI":"10.1590\/1677-5449.202300592","article-title":"Brazilian society of angiology and vascular surgery guidelines on peripheral artery disease","volume":"23","author":"Erzinger","year":"2024","journal-title":"J. Vasc. Bras."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200710_bib83","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jfma.2022.03.001","article-title":"2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: coronary artery disease, peripheral artery disease and ischemic stroke","volume":"121","author":"Chen","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200710_bib84","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","article-title":"JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome","volume":"83","author":"Kimura","year":"2019","journal-title":"Circ. J."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200710_bib85","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association\/american stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib86","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.0000000000200030","article-title":"Stroke prevention in symptomatic large artery intracranial atherosclerosis practice advisory: report of the AAN guideline subcommittee","volume":"98","author":"Turan","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ijcrp.2026.200710_bib87","author":"Foundation"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jfma.2016.11.013","article-title":"2017 Taiwan lipid guidelines for high risk patients","volume":"116","author":"Li","year":"2017","journal-title":"J. Formos. Med. Assoc."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib90","first-page":"4","article-title":"2023 guidelines of the Taiwan society of cardiology on the diagnosis and management of chronic coronary syndrome","volume":"39","author":"Ueng","year":"2023","journal-title":"Acta Cardiol. Sin."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib91","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.recesp.2019.07.024","article-title":"Recommendations to improve lipid control. Consensus document of the Spanish society of cardiology","volume":"73","author":"Escobar","year":"2020","journal-title":"Rev. Esp. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib92","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s40265-024-02105-5","article-title":"2024 recommendations on the optimal use of lipid-lowering therapy in established atherosclerotic cardiovascular disease and following acute coronary syndromes: a position paper of the international lipid expert panel (ILEP)","volume":"84","author":"Banach","year":"2024","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib93","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4070\/kcj.2024.0257","article-title":"2024 Korean society of myocardial infarction\/national evidence-based healthcare collaborating agency guideline for the pharmacotherapy of acute coronary syndromes","volume":"54","author":"Kim","year":"2024","journal-title":"Korean circulation journal"},{"key":"10.1016\/j.ijcrp.2026.200710_bib94","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.avsg.2023.08.023","volume":"100","author":"Mah\u00e9","year":"2024","journal-title":"Ann. Vasc. Surg."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200710_bib95","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/1747493020971970","article-title":"Recommendations for lipid modification in patients with ischemic stroke or transient ischemic attack: a clinical guide by the Hellenic stroke organization and the Hellenic atherosclerosis society","volume":"16","author":"Sagris","year":"2021","journal-title":"Int. J. Stroke"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nrl.2020.11.006","article-title":"Proprotein convertase subtilisin\/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: consensus document and practice guidance","volume":"37","author":"Gil-N\u00fa\u00f1ez","year":"2022","journal-title":"Neurologia"},{"key":"10.1016\/j.ijcrp.2026.200710_bib97","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.15420\/ecr.2021.36","article-title":"Asian Pacific society of cardiology consensus recommendations on dyslipidaemia","volume":"16","author":"Koh","year":"2021","journal-title":"Eur. Cardiol. Rev."},{"issue":"24","key":"10.1016\/j.ijcrp.2026.200710_bib98","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200710_bib99","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/17474930221090347","article-title":"Japan stroke society guideline 2021 for the treatment of stroke","volume":"17","author":"Miyamoto","year":"2022","journal-title":"Int. J. Stroke"},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200710_bib100","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ijcrp.2026.200710_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ctd\/160061","article-title":"Standards of care in diabetes. The position of diabetes Poland\u20132024","volume":"3","author":"Araszkiewicz","year":"2023","journal-title":"Curr Top Diabetes"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib102","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13098-017-0251-z","article-title":"Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian diabetes society (SBD), the Brazilian cardiology society (SBC) and the Brazilian endocrinology and metabolism Society (SBEM)","volume":"9","author":"Bertoluci","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200710_bib103","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eprac.2022.08.002","article-title":"American association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan\u20142022 update","volume":"28","author":"Blonde","year":"2022","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib104","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5603\/DK.a2022.0061","article-title":"Approach to a newly diagnosed adult with type 2 diabetes in the Indian context: recommendations by association of clinical endocrinologists consensus group","volume":"12","author":"Erukulapati","year":"2023","journal-title":"Clin. Diabetol."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4093\/dmj.2024.0249","article-title":"2023 clinical practice guidelines for diabetes management in Korea: full version recommendation of the Korean diabetes association","volume":"48","author":"Moon","year":"2024","journal-title":"Diabetes & Metabolism Journal"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib106","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12882-024-03664-1","article-title":"Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the joint association of British clinical diabetologists and UK kidney association (ABCD-UKKA) guideline 2024","volume":"25","author":"Zac-Varghese","year":"2024","journal-title":"BMC Nephrol."},{"issue":"39","key":"10.1016\/j.ijcrp.2026.200710_bib107","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the european society of cardiology (ESC)","volume":"44","author":"Marx","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13300-020-00961-4","article-title":"Latin American expert consensus for comprehensive management of type 2 diabetes from a metabolic\u2013cardio\u2013renal perspective for the primary care physician","volume":"12","author":"Mehta","year":"2021","journal-title":"Diabetes Therapy"},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200710_bib109","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 international society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcrp.2026.200710_bib110","series-title":"Prevention of Cardiovascular Disease in Women 2016","year":"2016"},{"issue":"Supplement_1","key":"10.1016\/j.ijcrp.2026.200710_bib111","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.2337\/dc25-S010","article-title":"Cardiovascular disease and risk management: standards of care in Diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200710_bib112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13340-020-00439-5","article-title":"Japanese clinical practice guideline for diabetes 2019","volume":"11","author":"Araki","year":"2020","journal-title":"Diabetology international"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib113","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/clinem\/dgaa674","article-title":"Lipid management in patients with endocrine disorders: an endocrine society clinical practice guideline","volume":"105","author":"Newman","year":"2020","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ijcrp.2026.200710_bib114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.65564\/pjim.ae40192771","article-title":"Approach to lower the cardiovascular risk of individuals with type 2 diabetes mellitus: evidence-Based consensus statements of the Philippine heart association and Philippine society of endocrinology diabetes and metabolism","author":"Sison","year":"2021","journal-title":"Philippine J. Intern. Med."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200710_bib116","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/jdv.19191","article-title":"Statins and psoriasis: position statement by the psoriasis task force of the european academy of dermatology and venerology","volume":"37","author":"Gonzalez\u2010Cantero","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4S","key":"10.1016\/j.ijcrp.2026.200710_bib117","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on managing modifiable risk in transplantation (COMMIT) group","volume":"101","author":"Neuberger","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcrp.2026.200710_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-017-0553-2","article-title":"Renal association clinical practice guideline in post-operative care in the kidney transplant recipient","volume":"18","author":"Baker","year":"2017","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ijcrp.2026.200710_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ijcrp.2026.200710_bib120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5603\/ah.103916","article-title":"Guidelines for the management of hypertension in Poland 2024\u2014the position of the Polish society of hypertension\/polish cardiac society experts","volume":"28","author":"Prejbisz","year":"2024","journal-title":"Arter. Hypertens."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib121","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1747493017743801","article-title":"Canadian stroke best practice consensus statement: secondary stroke prevention during pregnancy","volume":"13","author":"Swartz","year":"2018","journal-title":"Int. J. Stroke"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib122","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41569-023-00892-0","article-title":"International atherosclerosis society guidance for implementing best practice in the care of familial hypercholesterolaemia","volume":"20","author":"Watts","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"9753","key":"10.1016\/j.ijcrp.2026.200710_bib123","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Trialists","year":"2010","journal-title":"Lancet"},{"issue":"9841","key":"10.1016\/j.ijcrp.2026.200710_bib124","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Trialists","year":"2012","journal-title":"Lancet"},{"issue":"9976","key":"10.1016\/j.ijcrp.2026.200710_bib125","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-Lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials","volume":"385","author":"Trialists","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib126","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200710_bib127","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jacl.2026.02.006","article-title":"Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: a meta-analysis","volume":"20","author":"Kalra","year":"2026","journal-title":"J. Clin. Lipidol."},{"issue":"25","key":"10.1016\/j.ijcrp.2026.200710_bib128","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.ijcrp.2026.200710_bib129","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ijcrp.2026.200710_bib130","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijcrp.2026.200710_bib131","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMoa2600283","article-title":"Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease","volume":"394","author":"Lee","year":"2026","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ijcrp.2026.200710_bib132","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.2026.3277","article-title":"Evolocumab to reduce first major cardiovascular events in patients without known significant atherosclerosis and with diabetes: results from the VESALIUS-CV trial","volume":"335","author":"Marston","year":"2026","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib133","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2514428","article-title":"Evolocumab in patients without a previous myocardial infarction or stroke","volume":"394","author":"Bohula","year":"2026","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ijcrp.2026.200710_bib134","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCULATIONAHA.122.063399","article-title":"Association between achieved low-density lipoprotein cholesterol levels and long-term cardiovascular and safety outcomes: an analysis of FOURIER-OLE","volume":"147","author":"Gaba","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2026.200710_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1494234","article-title":"Recommendations for the primary prevention of atherosclerotic cardiovascular disease in primary care: a systematic guideline review","volume":"11","author":"Bredehorst","year":"2025","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200710_bib136","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001396","article-title":"Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events","volume":"7","author":"Brown","year":"2020","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12913-022-08975-3","article-title":"Approaches to clinical guideline development in healthcare: a scoping review and document analysis","volume":"23","author":"De Leo","year":"2023","journal-title":"BMC Health Serv. Res."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200710_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040250","article-title":"How evidence-based are the recommendations in evidence-based guidelines?","volume":"4","author":"McAlister","year":"2007","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib139","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12874-023-02101-5","article-title":"Advancing guideline quality through country-wide and regional quality assessment of CPGs using AGREE: a scoping review","volume":"23","author":"Mc Allister","year":"2023","journal-title":"BMC Med. Res. Methodol."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200710_bib140","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s11606-025-09472-z","article-title":"Physician perceptions, knowledge, and implementation of lipid-lowering guidelines in the USA","volume":"41","author":"Karmarkar","year":"2025","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200710_bib141","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezae237","article-title":"Clinical practice guidelines: ensuring quality through international collaboration","volume":"66","author":"Milojevic","year":"2024","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"key":"10.1016\/j.ijcrp.2026.200710_bib142","series-title":"Clinical Practice Guidelines we can Trust","article-title":"Institute of medicine committee on standards for developing trustworthy clinical practice G","year":"2011"},{"issue":"5S Suppl 2","key":"10.1016\/j.ijcrp.2026.200710_bib143","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/JMQ.0000000000000137","article-title":"An integrated process for Co-Developing and implementing written and computable clinical practice guidelines","volume":"38","author":"Matson-Koffman","year":"2023","journal-title":"Am. J. Med. Qual."},{"key":"10.1016\/j.ijcrp.2026.200710_bib144","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2020-059818","article-title":"Clinical decision support in cardiovascular medicine","volume":"377","author":"Lu","year":"2022","journal-title":"Bmj"},{"key":"10.1016\/j.ijcrp.2026.200710_bib145","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf175","article-title":"Cardiovascular risk factors management in older adults: a clinical consensus statement from the european association of preventive cardiology of the ESC and the ESC council for cardiology practice","author":"Pedretti","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200710_bib146","series-title":"Clinical Practice Guidelines for Obesity Management in Europe: Gaps and Needs","year":"2024"},{"key":"10.1016\/j.ijcrp.2026.200710_bib147","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias: developed by the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and the european atherosclerosis society (EAS)","author":"Mach","year":"2025","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijcrp.2026.200710_bib148","first-page":"e1154","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"153","author":"Blumenthal","year":"2026","journal-title":"Circulation"},{"issue":"0","key":"10.1016\/j.ijcrp.2026.200710_bib149","article-title":"AHA\/ACC statement on cost\/value methodology in clinical practice guidelines (update from 2014 statement): a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"0","author":"Kazi","year":"2025","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:37:50Z","timestamp":1793788670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":143,"alternative-id":["S2772487526001406"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200710","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of clinical guidance for lipid management in adults with or at risk of atherosclerotic cardiovascular disease: A global perspective","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s) and Merck & Co., Inc., Rahway, NJ, USA and its affiliates. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200710"}}